LexDanaLexDanabeta
Inventor

Michael D. Bentley

Inventor
Huntsville, AL, US

Overview

121→
Patents
1999–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 121 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C08LCompositions of macromolecular compounds7%
C07KPeptides5%
C07DHeterocyclic compounds4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%
C07CAcyclic or carbocyclic compounds3%
C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients3%
C12NMicroorganisms or enzymes2%
PatentTitleYear
11,065,340Polyoxazoline antibody drug conjugates202110,864,276Activated polyoxazolines and conjugates and compositions comprising the same202010,695,435Composition comprising a polymeric reagent202010,646,578Polymer derivatives having particular atom arrangements202010,463,659Multi-arm polymer prodrugs201910,426,768Subcutaneous delivery of polymer conjugates of therapeutic agents201910,314,837Subcutaneous delivery of poly(oxazoline) polymer conjugates201910,166,294Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same201910,130,720Composition comprising a polymeric reagent201810,086,084Activated polyoxazolines and conjugates and compositions comprising the same201810,071,168Polyoxazoline antibody drug conjugates201810,035,880Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation20189,999,657Polymer-factor VIII moiety conjugates20189,913,913'Method for preparing a polymeric reagent'20189,808,533'Multi-arm polymer prodrugs'20179,775,911'Composition comprising a polymeric reagent'20179,446,139'Polymer-based compositions and conjugates of HIV entry inhibitors'20169,399,070'Compositions comprising a polymeric reagent and a pharmacologically active agent'20169,388,104'Chemically modified small molecules'20169,381,254'Methods for preparing polymeric reagents'20169,333,200'Multi-arm polymer prodrugs'20169,284,411'Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds'20169,233,932'Oligomer-nitroimidazole anti-infective conjugates'20169,187,569'Branched polymers'20159,169,354'Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same'20159,090,740'Methods for preparing polymeric reagents'20159,044,516'Pharmaceutical compositions of conjugates formed from polymer derivatives having particular atom arrangements'20159,040,060'Hydrolytically degradable alkylene oxide based polymers'20158,940,801'Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation'20158,911,718'Methods for preparing polymeric reagents'20148,889,831'Unit dosage forms of pharmaceutical compositions comprising a polymer-factor VIII polypeptide conjugate'20148,883,211'Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds'20148,853,247'Oligomer-nitroimidazole anti-infective conjugates'20148,809,453'Branched polymers'20148,796,248'Oligomer-corticosteroid conjugates'20148,771,662'Multi-arm polymer prodrugs'20148,728,493'Polymer based compositions and conjugates of non-steroidal anti-inflammatory drugs'20148,703,115'Methods for preparing conjugates'20148,633,277'Methods for forming polymer-drug conjugates'20148,618,259'Polymer-factor VIII conjugate compositions'20138,617,530'Polymer conjugates of opioid antagonists'20138,597,633'Subcutaneous delivery of poly(oxazoline) conjugates'20138,563,726'Stereoselective reduction of a morphinone'20138,519,102'Polymer Factor VIII moiety conjugates'20138,501,899'Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same'20138,450,390'Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof'20138,440,623'Polymer stabilized neuropeptides'20138,440,816'Branched polymers'20138,435,505'Pharmaceutical compositions and methods for delivering such compositions'20138,394,365'Multi-arm polymer prodrugs'20138,383,380'Segmented polymers and their conjugates'20138,383,093'Subcutaneous delivery of poly(oxazoline) conjugates'20138,349,307'Polymer conjugates of opioid antagonists'20138,318,145'Multi-arm polymer prodrugs'20128,283,434'Hydrolytically degradable polymers and hydrogels made therefrom'20128,273,833'Branched Polymers'20128,263,062'Multi-arm polymer prodrugs'20128,252,275'Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates'20128,247,598'Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof'20128,247,536'Factor VIII compositions'20128,183,338'Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof'20128,183,376'Stereoselective reduction of a morphinone'20128,143,378'Polymer factor VIII moiety conjugates'20128,133,977'Polymer-factor VIII moiety conjugates'20128,119,756'Hydrolytically degradable polymers and hydrogels made therefrom'20128,110,651'Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same'20128,101,706'Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same'20128,097,695'Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof'20128,088,884'Multi-armed forms of activated polyoxazoline and methods of synthesis thereof'20128,084,572'Segmented polymers and their conjugates'20118,034,825'Chemically modified small molecules'20118,008,435'Polymer stabilized neuropeptides'20117,988,956'Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)'20117,960,502'Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof'20117,947,261'Conjugates formed from polymer derivatives having particular atom arrangements'20117,943,141'Activated polyoxazolines and compositions comprising the same'20117,910,685'Hydrolytically degradable polymers and hydrogels made therefrom'20117,887,789'Polymer derivatives having particular atom arrangements'20117,872,072'Branched polymers and their conjugates'20117,863,421'Polymer-factor VIII moiety conjugates'20117,858,749'Polymer-factor VIII moiety conjugates'20107,834,138'Segmented polymers and their conjugates'20107,786,133'Chemically modified small molecules'20107,772,357'Hydrolytically degradable polymers and hydrogels made therefrom'20107,744,861'Multi-arm polymer prodrugs'20107,674,879'Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof'20107,662,365'Polymer conjugates of opioid antagonists'20107,642,323'Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation'20107,608,678'Hydrolytically degradable polymers and hydrogels made therefrom'20097,608,253'Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)'20097,598,338'Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof'20097,405,266'Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof'20087,312,301'Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof'20077,268,210'PEG-LHRH analog conjugates'20077,259,224'Hydrolytically degradable polymers and hydrogels made therefrom'20077,205,380'Sterically hindered poly (ethylene glycol) alkanoic acids and derivatives thereof'20077,199,223'Polymer-factor VIII moiety conjugates'20077,074,878'Hydrolytically degradable polymers and hydrogels made therefrom'20067,060,259'Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)'20067,056,500'Polymer conjugates of opioid antagonists'20067,053,150'Segmented polymers and their conjugates'20067,026,440'Branched polymers and their conjugates'20066,992,168'Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof'20066,914,121'PEG-LHRH analog conjugates'20056,899,867'Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)'20056,864,327'Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation'20056,774,180'Synthesis of high molecular weight non-peptidic polymer derivatives'20046,737,505'Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof'20046,602,952'Hydrogels derived from chitosan and poly(ethylene glycol) or related polymers'20036,541,015'Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)'20036,514,491'Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)'20036,495,659'Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof'20026,461,602'Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)'20026,461,603'Water-soluble polymer conjugates of artelinic acid'20026,448,369'Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation'20026,433,135'PEG-LHRH analog conjugates'20026,413,507'Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)'20026,348,558'Hydrolytically degradable polymers and hydrogels made therefrom'20026,242,482'Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure'20016,161,308'Slimes treatment'20005,990,237'Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999–2021Based in Huntsville, AL, US· patent location history
2000Based in Benoni, ZA· patent location history
2004–2008Patents assigned to NEKTAR THERAPEUTICS AL CORP (14)· patent assignee history
2006–2015Patents assigned to BENTLEY MICHAEL DAVID (14)· patent assignee history
2009–2020Patents assigned to NEKTAR THERAPEUTICS (73)· patent assignee history
2011–2016Patents assigned to BENTLEY MICHAEL D (25)· patent assignee history
2011–2021Patents assigned to SERINA THERAPEUTICS INC (17)· patent assignee history
2013–2014Based in Hunstville, AL, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NEKTAR THERAPEUTICS732009–2020
BENTLEY MICHAEL Dself252011–2016
SERINA THERAPEUTICS INC172011–2021
BENTLEY MICHAEL DAVIDself142006–2015
NEKTAR THERAPEUTICS AL CORP142004–2008
Locations
LocationPatentsSpan
Huntsville, AL, US1181999–2021
Hunstville, AL, US22013–2014
Benoni, ZA12000